PL1917959T3 - Nowe medyczne zastosowanie alfa-ketoglutaranu - Google Patents

Nowe medyczne zastosowanie alfa-ketoglutaranu

Info

Publication number
PL1917959T3
PL1917959T3 PL07460015T PL07460015T PL1917959T3 PL 1917959 T3 PL1917959 T3 PL 1917959T3 PL 07460015 T PL07460015 T PL 07460015T PL 07460015 T PL07460015 T PL 07460015T PL 1917959 T3 PL1917959 T3 PL 1917959T3
Authority
PL
Poland
Prior art keywords
bacteria
ureolytic
ureolytic bacteria
ketoglutarate
infections
Prior art date
Application number
PL07460015T
Other languages
English (en)
Inventor
Danuta Kruszewska
Original Assignee
Danuta Kruszewska
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Danuta Kruszewska filed Critical Danuta Kruszewska
Publication of PL1917959T3 publication Critical patent/PL1917959T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Detergent Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL07460015T 2006-07-03 2007-07-03 Nowe medyczne zastosowanie alfa-ketoglutaranu PL1917959T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PL380103A PL226695B1 (pl) 2006-07-03 2006-07-03 Środek do zastosowania w zapobieganiu i/lub hamowaniu kolonizacji Helicobacter pylori, zastosowanie soli kwasu alfa‑ketoglutarowego z metalami alkalicznymi i ziem alkalicznych do wytwarzania środka leczniczego oraz dodatku do żywności do zapobiegania i/lub hamowania kolonizacji Helicobacter pylori
EP07460015A EP1917959B1 (en) 2006-07-03 2007-07-03 New medical use of alfa-ketoglutarate

Publications (1)

Publication Number Publication Date
PL1917959T3 true PL1917959T3 (pl) 2011-06-30

Family

ID=38984524

Family Applications (2)

Application Number Title Priority Date Filing Date
PL380103A PL226695B1 (pl) 2006-07-03 2006-07-03 Środek do zastosowania w zapobieganiu i/lub hamowaniu kolonizacji Helicobacter pylori, zastosowanie soli kwasu alfa‑ketoglutarowego z metalami alkalicznymi i ziem alkalicznych do wytwarzania środka leczniczego oraz dodatku do żywności do zapobiegania i/lub hamowania kolonizacji Helicobacter pylori
PL07460015T PL1917959T3 (pl) 2006-07-03 2007-07-03 Nowe medyczne zastosowanie alfa-ketoglutaranu

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL380103A PL226695B1 (pl) 2006-07-03 2006-07-03 Środek do zastosowania w zapobieganiu i/lub hamowaniu kolonizacji Helicobacter pylori, zastosowanie soli kwasu alfa‑ketoglutarowego z metalami alkalicznymi i ziem alkalicznych do wytwarzania środka leczniczego oraz dodatku do żywności do zapobiegania i/lub hamowania kolonizacji Helicobacter pylori

Country Status (10)

Country Link
US (1) US20100124537A1 (pl)
EP (1) EP1917959B1 (pl)
AT (1) ATE495738T1 (pl)
DE (1) DE602007012036D1 (pl)
DK (1) DK1917959T3 (pl)
ES (1) ES2360142T3 (pl)
HR (1) HRP20110268T1 (pl)
IL (1) IL233342A (pl)
PL (2) PL226695B1 (pl)
SI (1) SI1917959T1 (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7981908B2 (en) 2005-05-11 2011-07-19 Vecta, Ltd. Compositions and methods for inhibiting gastric acid secretion
US7803817B2 (en) 2005-05-11 2010-09-28 Vecta, Ltd. Composition and methods for inhibiting gastric acid secretion
PL2046334T3 (pl) 2006-07-25 2015-02-27 Vecta Ltd Kompozycje i sposoby hamowania wydzielania kwasów żołądkowych z wykorzystaniem pochodnych małych kwasów dikarboksylowych w połączeniu z PPI
SE0602446L (sv) * 2006-11-16 2008-05-17 Entress Ab Ny användning av kända farmakologiskt aktiva kemiska sammansättningar
EP2468319B1 (en) 2010-11-29 2016-11-23 Eurochit Danuta Kruszewska New nanoproduct useful in prophilaxis, diagnostics and medical and veterinary treatment
CN104684565A (zh) 2012-05-29 2015-06-03 达努塔·克鲁谢夫斯卡 在人类和兽医的预防和医疗中有用的、包含罗伊氏乳杆菌dan080的纳米产品及其医疗用途
EP2674162A1 (en) 2012-05-29 2013-12-18 Danuta Kruszewska Nanoproduct comprising lactobacillus reuteri dan080 useful in prophylaxis and medicine, both human and veterinary and medical use of the same
CA2884592C (en) 2012-09-19 2021-08-31 Grespo Ab Compositions for improvement of brain function
CN103923900B (zh) * 2014-04-14 2016-03-23 江南大学 一种黄酒用双功能酶交联酶聚集体的制备与应用
EP3518915A4 (en) * 2016-09-30 2020-04-15 The Regents of the University of California ALPHA KETOBUTYRATE, ALPHA KETOGLUTARATE AND 2-HYDROXYBUTYRATE FOR STIMULATING HAIR GROWTH
SG10202107237SA (en) * 2017-04-25 2021-08-30 Buck Inst Res Aging Formulations for extending lifespan and healthspan
KR102833111B1 (ko) 2018-09-25 2025-07-10 폰세 드 리온 헬스 데지그네이티드 액티비티 컴퍼니 칼슘 알파-케토글루타레이트의 제조 방법
WO2020086733A1 (en) * 2018-10-24 2020-04-30 Ponce De Leon Health Designated Activity Company Nicotinamide riboside compositions for healthspan extension
CA3188646A1 (en) * 2020-07-02 2022-01-06 Ponce De Leon Health Designated Activity Company Compositions and methods for treating crp-mediated diseases
CN115340313B (zh) * 2022-01-17 2023-04-18 浙江理工大学 一种物理复合微生物技术强化再生骨料方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4919855B1 (pl) 1970-10-06 1974-05-21
US4256731A (en) * 1978-03-23 1981-03-17 Beecham, Inc. Oral Compositions
US5028412A (en) * 1987-05-01 1991-07-02 Purdue Research Foundation Oral compositions comprising anti-calculus agents
US5817294A (en) * 1990-11-02 1998-10-06 Arnold; Michael J. Plaque adsorbent oral composition and method
JP2002529545A (ja) * 1998-11-06 2002-09-10 ユニベルシテ ドゥ モントリオール バイオフィルムを除去するための改良型の殺菌性及び非殺菌性溶液
FR2822704B1 (fr) * 2001-03-29 2005-02-18 Chiesi Sa Sels de cetoacides et d'acides amines gastroresistants et leur utilisation pour la preparation de medicaments
US7122578B2 (en) * 2001-09-11 2006-10-17 Alain Martin Method and composition for treating mammalian diseases and injuries which cause pain, erythema, swelling, crusting, ischemia scarring and excess white blood cell infiltration
SE0200256D0 (sv) * 2001-12-21 2002-01-29 Gramineer Internat Ab New composition, methods and use
PL368572A1 (pl) * 2004-06-17 2005-12-27 Sgp & Sons Ab Preparat farmaceutyczny do stosowania w profilaktyce i leczeniu podwyższonego poziomu cholesterolu,LDL oraz trójglicerydów oraz zastosowanie preparatu farmaceutycznego jako czynnika przeciwmiażdżycowego stosowanego w schorzeniach układu krążenia
US7803817B2 (en) * 2005-05-11 2010-09-28 Vecta, Ltd. Composition and methods for inhibiting gastric acid secretion
AU2006316059A1 (en) 2005-11-15 2007-05-24 Entress Ab Medicament for use in connection with cartilage impairment
KR20080102372A (ko) * 2006-01-19 2008-11-25 엔트레스 에이비 진단 방법 및 치료 방법

Also Published As

Publication number Publication date
SI1917959T1 (sl) 2011-05-31
PL226695B1 (pl) 2017-08-31
IL233342A0 (en) 2014-08-31
EP1917959B1 (en) 2011-01-19
IL233342A (en) 2016-05-31
DE602007012036D1 (de) 2011-03-03
DK1917959T3 (da) 2011-05-09
US20100124537A1 (en) 2010-05-20
EP1917959A1 (en) 2008-05-07
PL380103A1 (pl) 2008-01-07
ES2360142T3 (es) 2011-06-01
HRP20110268T1 (hr) 2011-05-31
ATE495738T1 (de) 2011-02-15

Similar Documents

Publication Publication Date Title
SI1917959T1 (sl) Nova medicinska uporaba alfa-ketoglutarata
JP2010532347A5 (pl)
BRPI0902901B8 (pt) bacteriófago e composição antibacteriana, alimento para animais, água potável, desinfetante, agente de limpeza e método para tratamento de doenças infecciosas compreendendo o mesmo
JP2011530534A5 (pl)
AU2010321992A1 (en) Biofilm disruptive compositions
JPH09508921A (ja) 殺菌剤としての酸性化したニトリット
JP2019524877A5 (pl)
JP4146146B2 (ja) フロロタンニン類を主成分とする抗菌剤
BR112021022632A2 (pt) Composições e métodos para tratar condições pulmonares relacionadas a biofilmes
CN103690937A (zh) 一种含海洋生物成分的儿童用龋齿口腔喷剂及其制备方法
Jo et al. Antimicrobial resistance in Escherichia coli isolated from shellfish farms on the west coast of Korea
CN104054753A (zh) 杀灭禽流感病毒的抗菌杀菌消毒剂
TW200920346A (en) Organic compounds
BR112019003890A2 (pt) uso de oligossacarídeos de leite humano em engordamento de bezerros
HRP20110479T1 (hr) Prirodna mineralna voda za upotrebu kod profilakse, higijene i tretmana zuba i paradontnih bolesti
JP2010095489A (ja) 病原性細菌の毒素産生抑制剤
Ismail et al. Silver nanoparticles and sodium hypochlorite inhibitory effects on biofilm produced by Pseudomonas aeruginosa from poultry farms
Magdalenić et al. Antibacterial activity of Croatian honey of different botanical origin
JP2010513431A5 (pl)
Moses-Otutu et al. Microbial contamination of tooth brushes and tooth brush keeping places among apparently healthy individuals in Egor LGA, Benin City
RU2583890C2 (ru) Способ лечения гингивитов, пародонтитов и зубного камня у собак
Panigrahi et al. TOPIC: IMMUNOGLOBULIN Y IN IMPROVING ORAL HEALTH IN CHILDREN: A COMPREHENSIVE REVIEW
W Williams et al. The oral cavity, biofilms and ventilator-associated pneumonia
Jawad et al. The investigation effect of storage place on bacterial contamination toothbrushes
Polanco Z et al. Gastric lesions associated with the presence of bacteria of the helicobacter genusin canine